308 related articles for article (PubMed ID: 25621499)
1. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus.
Byrska-Bishop M; VanDorn D; Campbell AE; Betensky M; Arca PR; Yao Y; Gadue P; Costa FF; Nemiroff RL; Blobel GA; French DL; Hardison RC; Weiss MJ; Chou ST
J Clin Invest; 2015 Mar; 125(3):993-1005. PubMed ID: 25621499
[TBL] [Abstract][Full Text] [Related]
2. Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.
Chlon TM; McNulty M; Goldenson B; Rosinski A; Crispino JD
Haematologica; 2015 May; 100(5):575-84. PubMed ID: 25682601
[TBL] [Abstract][Full Text] [Related]
3. Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis.
Ling T; Birger Y; Stankiewicz MJ; Ben-Haim N; Kalisky T; Rein A; Kugler E; Chen W; Fu C; Zhang K; Patel H; Sikora JW; Goo YA; Kelleher N; Zou L; Izraeli S; Crispino JD
Blood; 2019 Nov; 134(19):1619-1631. PubMed ID: 31409672
[TBL] [Abstract][Full Text] [Related]
4. Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of
Barwe SP; Sebastian A; Sidhu I; Kolb EA; Gopalakrishnapillai A
Cells; 2022 Feb; 11(4):. PubMed ID: 35203280
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Juban G; Sakakini N; Chagraoui H; Cruz Hernandez D; Cheng Q; Soady K; Stoilova B; Garnett C; Waithe D; Otto G; Doondeea J; Usukhbayar B; Karkoulia E; Alexiou M; Strouboulis J; Morrissey E; Roberts I; Porcher C; Vyas P
Haematologica; 2021 Apr; 106(4):1106-1119. PubMed ID: 32527952
[TBL] [Abstract][Full Text] [Related]
7. Single-cell transcriptomics reveal synergistic and antagonistic effects of T21 and GATA1s on hematopoiesis.
Takasaki K; Wafula EK; Kumar SS; Smith D; Gagne AL; French DL; Thom CS; Chou ST
bioRxiv; 2024 May; ():. PubMed ID: 38826323
[TBL] [Abstract][Full Text] [Related]
8. Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis.
Sit YT; Takasaki K; An HH; Xiao Y; Hurtz C; Gearhart PA; Zhang Z; Gadue P; French DL; Chou ST
JCI Insight; 2023 Oct; 8(23):. PubMed ID: 37906251
[TBL] [Abstract][Full Text] [Related]
9. Establishment of erythroleukemic GAK14 cells and characterization of GATA1 N-terminal domain.
Mukai HY; Suzuki M; Nagano M; Ohmori S; Otsuki A; Tsuchida K; Moriguchi T; Ohneda K; Shimizu R; Ohneda O; Yamamoto M
Genes Cells; 2013 Oct; 18(10):886-98. PubMed ID: 23890289
[TBL] [Abstract][Full Text] [Related]
10. Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.
Birger Y; Goldberg L; Chlon TM; Goldenson B; Muler I; Schiby G; Jacob-Hirsch J; Rechavi G; Crispino JD; Izraeli S
Blood; 2013 Aug; 122(6):988-98. PubMed ID: 23719302
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies.
Kazuki Y; Yakura Y; Abe S; Osaki M; Kajitani N; Kazuki K; Takehara S; Honma K; Suemori H; Yamazaki S; Sakuma T; Toki T; Shimizu R; Nakauchi H; Yamamoto T; Oshimura M
Sci Rep; 2014 Aug; 4():6136. PubMed ID: 25159877
[TBL] [Abstract][Full Text] [Related]
12. Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology.
Barwe SP; Sidhu I; Kolb EA; Gopalakrishnapillai A
Mol Ther Methods Clin Dev; 2020 Dec; 19():201-209. PubMed ID: 33102613
[TBL] [Abstract][Full Text] [Related]
13. The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice.
Ishihara D; Hasegawa A; Hirano I; Engel JD; Yamamoto M; Shimizu R
Exp Hematol Oncol; 2024 Feb; 13(1):24. PubMed ID: 38409186
[TBL] [Abstract][Full Text] [Related]
14. GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
Maroz A; Stachorski L; Emmrich S; Reinhardt K; Xu J; Shao Z; Käbler S; Dertmann T; Hitzler J; Roberts I; Vyas P; Juban G; Hennig C; Hansen G; Li Z; Orkin S; Reinhardt D; Klusmann JH
Leukemia; 2014 Jun; 28(6):1259-70. PubMed ID: 24336126
[TBL] [Abstract][Full Text] [Related]
15. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
[TBL] [Abstract][Full Text] [Related]
16. A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.
Zucker J; Temm C; Czader M; Nalepa G
Pediatr Blood Cancer; 2016 May; 63(5):917-21. PubMed ID: 26713410
[TBL] [Abstract][Full Text] [Related]
17. The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells.
Halsey C; Docherty M; McNeill M; Gilchrist D; Le Brocq M; Gibson B; Graham G
J Hematol Oncol; 2012 Aug; 5():45. PubMed ID: 22853316
[TBL] [Abstract][Full Text] [Related]
18. Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells.
Noh JY; Gandre-Babbe S; Wang Y; Hayes V; Yao Y; Gadue P; Sullivan SK; Chou ST; Machlus KR; Italiano JE; Kyba M; Finkelstein D; Ulirsch JC; Sankaran VG; French DL; Poncz M; Weiss MJ
J Clin Invest; 2015 Jun; 125(6):2369-74. PubMed ID: 25961454
[TBL] [Abstract][Full Text] [Related]
19. Lineage-specific combinatorial action of enhancers regulates mouse erythroid Gata1 expression.
Drissen R; Guyot B; Zhang L; Atzberger A; Sloane-Stanley J; Wood B; Porcher C; Vyas P
Blood; 2010 Apr; 115(17):3463-71. PubMed ID: 20154211
[TBL] [Abstract][Full Text] [Related]
20. Regulation of GATA1 levels in erythropoiesis.
Gutiérrez L; Caballero N; Fernández-Calleja L; Karkoulia E; Strouboulis J
IUBMB Life; 2020 Jan; 72(1):89-105. PubMed ID: 31769197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
